These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21206361)

  • 21. Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials.
    McIntyre RS; Muzina DJ; Adams A; Lourenco MT; Law CW; Soczynska JK; Woldeyohannes HO; Nathanson J; Kennedy SH
    Expert Opin Pharmacother; 2009 Dec; 10(18):3061-75. PubMed ID: 19954275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL.
    Modell JG; Rosenthal NE; Harriett AE; Krishen A; Asgharian A; Foster VJ; Metz A; Rockett CB; Wightman DS
    Biol Psychiatry; 2005 Oct; 58(8):658-67. PubMed ID: 16271314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is duloxetine effective treatment for depression with atypical features?
    Stewart JW; Deliyannides DA; McGrath PJ
    Int Clin Psychopharmacol; 2008 Nov; 23(6):333-6. PubMed ID: 18854721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term preventive care in depression: the use of bupropion in patients intolerant of other antidepressants.
    Gardner EA
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):157-62. PubMed ID: 6406449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving antidepressant adherence.
    Nemeroff CB
    J Clin Psychiatry; 2003; 64 Suppl 18():25-30. PubMed ID: 14700452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the safety and efficacy of bupropion in depression.
    Halaris AE; Stern WC; Van Wyck Fleet J; Reno RM
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):101-3. PubMed ID: 6406435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between baseline severity of depression and antidepressant treatment outcome.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Kronmüller K; Holsboer F; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Riedel M; Möller HJ
    Pharmacopsychiatry; 2011 Jan; 44(1):27-32. PubMed ID: 20981642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with antidepressant use in depressed and non-depressed community-dwelling elderly: the three-city study.
    Soudry A; Dufouil C; Ritchie K; Dartigues JF; Tzourio C; Alpérovitch A
    Int J Geriatr Psychiatry; 2008 Mar; 23(3):324-30. PubMed ID: 17907265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duloxetine 60 mg once daily in the treatment of milder major depressive disorder.
    Perahia DG; Kajdasz DK; Walker DJ; Raskin J; Tylee A
    Int J Clin Pract; 2006 May; 60(5):613-20. PubMed ID: 16700869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
    Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
    J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.
    Tulen JH; Volkers AC; van den Broek WW; Bruijn JA
    J Clin Psychopharmacol; 2006 Oct; 26(5):542-4. PubMed ID: 16974207
    [No Abstract]   [Full Text] [Related]  

  • 32. A pilot study of acupuncture augmentation therapy in antidepressant partial and non-responders with major depressive disorder.
    Yeung AS; Ameral VE; Chuzi SE; Fava M; Mischoulon D
    J Affect Disord; 2011 Apr; 130(1-2):285-9. PubMed ID: 20692042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bupropion normalizes cognitive performance in patients with depression.
    Gualtieri CT; Johnson LG
    MedGenMed; 2007 Jan; 9(1):22. PubMed ID: 17435629
    [No Abstract]   [Full Text] [Related]  

  • 34. Bupropion-induced hyponatremia.
    Kate N; Grover S; Kumar S; Modi M
    Gen Hosp Psychiatry; 2013; 35(6):681.e11-2. PubMed ID: 23764348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bupropion SR reduces periodic limb movements associated with arousals from sleep in depressed patients with periodic limb movement disorder.
    Nofzinger EA; Fasiczka A; Berman S; Thase ME
    J Clin Psychiatry; 2000 Nov; 61(11):858-62. PubMed ID: 11105739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delirium associated with concomitant use of duloxetine and bupropion in an elderly patient.
    Ma SP; Tsai CJ; Chang CC; Hsu WY
    Psychogeriatrics; 2017 Mar; 17(2):130-132. PubMed ID: 27046219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of bupropion-induced stuttering.
    Fetterolf F; Marceau M
    Gen Hosp Psychiatry; 2013; 35(5):574.e7-8. PubMed ID: 22959418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Experience With High-Dosage Pramipexole in Patients With Treatment-Resistant Depressive Episodes in Unipolar and Bipolar Depression.
    Fawcett J; Rush AJ; Vukelich J; Diaz SH; Dunklee L; Romo P; Yarns BC; Escalona R
    Am J Psychiatry; 2016 Feb; 173(2):107-11. PubMed ID: 26844792
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparing outcomes of adjunctive treatment in depression: aripiprazole versus bupropion.
    Nasr S; Wendt B; Popli A; Crayton J
    J Affect Disord; 2014 Jun; 162():50-4. PubMed ID: 24767005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of U.S. Veteran Patients with Major Depressive Disorder who require "next-step" treatments: A VAST-D report.
    Zisook S; Tal I; Weingart K; Hicks P; Davis LL; Chen P; Yoon J; Johnson GR; Vertrees JE; Rao S; Pilkinton PD; Wilcox JA; Sapra M; Iranmanesh A; Huang GD; Mohamed S
    J Affect Disord; 2016 Dec; 206():232-240. PubMed ID: 27479536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.